Clinical Trial Update: Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of everolimus in locally advanced or metastatic thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Thyroid Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Yonsei University | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED